Subscribe To
Lumiradx receives uk ctda approval for covid ultra and covid & rsv tests
LumiraDx SARS-CoV-2 Ag Ultra & SARS-CoV-2 Ag & RSV tests have been successfully validated by the Medicines and Healthcare products Regulatory Agency (...
June 20, 2023, 8:15 pm
Wall street giants propel edx markets into digital asset trading scene
EDX Markets, a new digital asset marketplace, has announced the successful initiation of its trading op...
June 20, 2023, 5:37 pm
Healthrecon connect successfully appraised at cmmi level 3
DALLAS, June 20, 2023 (GLOBE NEWSWIRE) — HealthRecon Connect, a leading technology enabled revenue cycle management solutions provider to US Healthc...
June 20, 2023, 4:41 pm
Vivakor announces relocation of remediation processing center 2 to kuwait with revenue generation expected in 2024
Vivakor said it is relocating its Remediation Processing Center 2 (RPC #2) from Vernal in Utah to Kuwait based on ...
June 20, 2023, 10:01 am
Guild esports raises cash to enter 'exiting' racing category
Guild Esports said it successfully raised £622,200, with proceeds used for general working capital purposes and to enter into the “exciting” race...
June 20, 2023, 2:33 am
Tusimple tests removing human driver from self-driving truck in china
Autonomous trucking company TuSimple last week successfully completed a fully autonomous semi-truck run on public roads in China without a human prese...
June 19, 2023, 9:44 pm
Heineken: a premium company at a decent price
Heineken's litany of strategies aimed at growth and sustainability are well-thought and have been successful <...
June 19, 2023, 1:27 pm
Naga successfully secures $8.2m funding and promotes new ceo
NAGA Group, the German-based fintech company that operates the neo-broker, NAGA, informed today (Monday) that it successfully closed the $8.2 million ...
June 19, 2023, 12:33 pm
Ic markets launches series 3 of ic your trade podcast
IC Markets noted: ICYT has already received recognition, with an industry award for ‘Branded Business Show and Advertising’ from Signal Awards and...
June 19, 2023, 7:32 am
Surprise! why rivian stock could soar by 2025.
In the competitive and rapidly changing electric vehicle industry, Rivian ( RIVN ) has become a highly debated stock. After its ...
June 19, 2023, 6:40 am
Arista networks: huge potential at an attractive valuation
Arista Networks is well-positioned to benefit from the growth in artificial intelligence due to its leading position in the data center equipment spac...
June 19, 2023, 4:31 am
Zuora: take advantage of this momentum (price target increase)
Zuora, a subscription revenue-management software company, has seen its share price jump ~75% year to date, with potential for further growth. Zuora h...
June 18, 2023, 12:01 pm
Hygv: smart beta high yield fund
The FlexShares High Yield Value-Scored Bond Index Fund (HYGV) is a smart beta ETF that focuses on the U.S. high yield market. The fund follows an inde...
June 18, 2023, 7:07 am
Chinook therapeutics presents data from chk-336 phase 1 trial in healthy volunteers and new insights into the role of failed repair in chronic kidney disease at the 60th european renal association (er
CHK-336 was generally well tolerated in healthy volunteers (HV) who received single doses up to 500 mg and multiple doses up to 60 mg for 14 days Phar...
June 17, 2023, 11:15 am
Chinook therapeutics presents data from chk-336 phase 1 trial in healthy volunteers and new insights into the role of failed repair in chronic kidney disease at the 60th european renal association (er
CHK-336 was generally well tolerated in healthy volunteers (HV) who received single doses up to 500 mg and multiple doses up to 60 mg for 14 days Phar...
June 17, 2023, 11:15 am
Chinook therapeutics presents data from chk-336 phase 1 trial in healthy volunteers and new insights into the role of failed repair in chronic kidney disease at the 60th european renal association (er
CHK-336 was generally well tolerated in healthy volunteers (HV) who received single doses up to 500 mg and multiple doses up to 60 mg for 14 days Phar...
June 17, 2023, 11:15 am
Chinook therapeutics presents data from chk-336 phase 1 trial in healthy volunteers and new insights into the role of failed repair in chronic kidney disease at the 60th european renal association (er
CHK-336 was generally well tolerated in healthy volunteers (HV) who received single doses up to 500 mg and multiple doses up to 60 mg for 14 days Phar...
June 17, 2023, 11:15 am
Chinook therapeutics presents data from chk-336 phase 1 trial in healthy volunteers and new insights into the role of failed repair in chronic kidney disease at the 60th european renal association (er
CHK-336 was generally well tolerated in healthy volunteers (HV) who received single doses up to 500 mg and multiple doses up to 60 mg for 14 days Phar...
June 17, 2023, 11:15 am
Chinook therapeutics presents data from chk-336 phase 1 trial in healthy volunteers and new insights into the role of failed repair in chronic kidney disease at the 60th european renal association (er
CHK-336 was generally well tolerated in healthy volunteers (HV) who received single doses up to 500 mg and multiple doses up to 60 mg for 14 days Phar...
June 17, 2023, 11:15 am
Xeris biopharma: remarkable market share expansion
Xeris Biopharma Holdings Inc is a growing healthcare company with strong revenue growth and a solid balance sheet, making it an attractive investment ...
June 16, 2023, 8:41 pm